<DOC>
	<DOCNO>NCT00457509</DOCNO>
	<brief_summary>The purpose study test different adjuvanted vaccine formulation two-dose schedule immunologically naïve adult one vaccine formulation without adjuvant term tolerance immunogenicity Primary Objective : To describe safety profile immunogenicity follow injection .</brief_summary>
	<brief_title>Safety Immunogenicity H5N1 Adjuvanted , Inactivated , Split-Virion Pandemic Influenza Vaccine Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Aged 18 40 year day inclusion Informed consent form sign Able attend schedule visit comply trial procedure For woman , inability bear child negative urine pregnancy test . Exclusion Criteria : Participation another clinical trial 4 week precede first trial vaccination . Planned participation another clinical trial present trial period . Previous participation clinical trial involve investigational flu pandemic vaccine . Vaccination influenza vaccine past 6 month Any vaccination 4 week precede first trial vaccination Vaccination plan 4 week follow trial vaccination Breastfeeding . For woman childbearing potential , absence effective method contraception abstinence non observe least 4 week prior first vaccination least 4 week last vaccination . Congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy . Known human immunodeficiency virus ( HIV ) , hepatitis B ( AgHBs ) hepatitis C seropositivity . Known systemic hypersensitivity egg protein , chick protein , vaccine component , history lifethreatening reaction trial vaccine vaccine contain substance . Thrombocytopenia bleed disorder contraindicate intramuscular vaccination . Chronic illness stage could interfere trial conduct completion . Current abuse alcohol drug addiction may interfere subject 's ability comply trial procedure . Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent . Blood bloodderived product receive past 3 month . Febrile illness ( temperature ≥ 37.5°C ) day inclusion . Laboratory abnormality consider clinically significant upon Investigator 's judgment blood sample take screening ( Step 1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pandemic influenza</keyword>
	<keyword>Avian influenza</keyword>
	<keyword>Orthomyxoviridae Infections</keyword>
	<keyword>A/H5N1</keyword>
</DOC>